Clinical Trials Browser

Unknown × OTHER × Patient Reported Outcome Measures × Clear all

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT04146064 2023-06-05

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

Unknown

425 enrolled

DermatologicGenitourinaryHead & Neck

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

NCT04292353 2021-05-05

WP-12

Unknown

67 enrolled

CNS

Brain Neoplasms, Radiation Injuries, Cognitive Dysfunction

NCT02304614 2020-10-22

3DBCT

Unknown

346 enrolled

Breast

Breast Neoplasms

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Phase 2 Unknown

74 enrolled

Gastrointestinal

Fatigue, Rectal Neoplasms

Clinical Trials

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

WP-12

3DBCT

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)